The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem worldwide and an important risk factor for both hepatic and cardiometabolic mortality. The rapidly increasing prevalence of this disease and of its aggressive form nonalcoholic steatohepatitis (NASH) will require novel therapeutic approaches based on a profound understanding of its pathogenesis to halt disease progression to advanced fibrosis or cirrhosis and cancer. The pathogenesis of NAFLD involves a complex interaction among environmental factors (i.e., Western diet), obesity, changes in microbiota, and predisposing genetic variants resulting in a disturbed lipid homeostasis and an excessive accumulation of triglycerides and other lipid species in hepatocytes. Insulin resistance is a central mechanism that leads to lipotoxicity, endoplasmic reticulum stress, disturbed autophagy, and, ultimately, hepatocyte injury and death that triggers hepatic inflammation, hepatic stellate cell activation, and progressive fibrogenesis, thus driving disease progression. In the present review, we summarize the currently available data on the pathogenesis of NAFLD, emphasizing the most recent advances. A better understanding of NAFLD/NASH pathogenesis is crucial for the design of new and efficient therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BAs have emerged as important pathogenetic factors and therapeutic targets in both cholestatic and metabolic liver diseases.4 13 41”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
Convergent pathways that cause hepatic fibrosis in NASH
Friedman, S. L. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.256 · Cited by 58
Jiang, J. X., Mikami, K., Shah, V. H., & Torok, N. J. (2008) · Hepatology · doi:10.1002/hep.22515 · Cited by 54
Jiang, J. X., Chen, X., Fukada, H., Serizawa, N., Devaraj, S., & Török, N. J. (2013) · Hepatology · doi:10.1002/hep.26491 · Cited by 49
Bigorgne, A., John, B., Ebrahimkhani, M. R., Shimizu‐Albergine, M., Campbell, J. S., & Crispe, I. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151063 · Cited by 47
Berk, P. D. (2008) · Hepatology · doi:10.1002/hep.22632 · Cited by 46
Leptin and liver tissue repair: Do rodent models provide the answers?
Marra, F. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.002 · Cited by 38
Xu, C., Wang, G., Hao, Y., Zhi, J., Zhang, L., & Chang, C. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1599-9 · Cited by 35
Shiffman, M. L., Freilich, B. L., Vuppalanchi, R., Watt, K. D. S., Burgess, G., Morris, M., Sheedy, B., & Schiff, E. R. (2015) · Journal of Hepatology · doi:10.1016/s0168-8278(15)30191-4 · Cited by 31
Hypoadiponectinemia and its Association with Liver Fibrosis in Morbidly Obese Patients
Nazal, L., Riquelme, A. J., Solı́s, N., Pizarro, M., Escalona, A., Burotto, M., Méndez, J. I., Saint-Jean, C., Concha, M. J., Giovanni, S., et al. (2010) · Obesity Surgery · doi:10.1007/s11695-009-0051-0 · Cited by 30
Self-citationFlechtner‐Mors, M., George, S. N., Oeztuerk, S., Haenle, M. M., Köenig, W., Imhof, A., Boehm, B. O., Graeter, T., Mason, R. A., Kratzer, W., et al. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-207 · Cited by 22
Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients
D’Incao, R. B., Tovo, C. V., Mattevi, V. S., Borges, D. O., Ulbrich, J. M., Coral, G. P., Ramos, M. J., & Meinhardt, N. G. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2627-4 · Cited by 16
Arab, J. P., Hernández-Rocha, C., Morales, C., et al. (2017) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2017.02.009 · Cited by 13
Self-citationStatins and non-alcoholic steatohepatitis
Athyros, V. G., Katsiki, N., Karagiannis, A. I., & Mikhailidis, D. P. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.09.021 · Cited by 11
Epidemiological Trends in NASH as a Cause for Liver Transplant
Siow, W., van der Poorten, D., & George, J. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0294-x · Cited by 10
Nonalcoholic steatohepatitis and the intestinal microbiota
Haslam, D. B. (2016) · Hepatology · doi:10.1002/hep.28864 · Cited by 10
(2016) · Hepatology · doi:10.1002/hep.28909 · Cited by 9
Mechanisms of Fibrosis in Steatohepatitis
Marra, F., Provenzano, A., & Vivoli, E. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0228-4 · Cited by 3
Bates, J. G., Brockett, R., Mikaelian, I., Wang, T., Ray, A. S., Tumas, D. B., & Breckenridge, D. G. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31226-6 · Cited by 1
Research works printed but not linked: 6
- Arab JP, 2016, Ann. Hepatol., 15, 721
- Berlanga A, 2014, Clin. Exp. Gastroenterol., 7, 221
- 10.1002/cphy.c120035 · DOI · Paper page
- Mao J-W, 2015, Int. J. Clin. Exp. Pathol., 8, 3648
- de Mesquita FC, 2015, Hepatology, 62, 901A
- Loomba R, 2016, Hepatology, 64, 1119A
Cited by
Sorted by citations
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.11.013 · Cited by 262
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
Self-citationNovel therapeutic targets for cholestatic and fatty liver disease
Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204
Self-citationShi, Y., Su, W., Zhang, L., Shi, C., Zhou, J., Wang, P., Wang, H., Shi, X., Wei, S., Wang, Q., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609060 · Cited by 177
Metadata
- Authors
- Arab, J. P., Arrese, M., & Trauner, M.
- Affiliations
- Mayo Clinic (US)
- Pontificia Universidad Católica de Chile (CL)
- Medical University of Vienna (AT)
- Corresponding author
- Trauner, Michael
- Venue
- Annual Review of Pathology Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2018-01-24
- Volume
- 13
- Issue
- 1
- Pages
- 321-350
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2785779482
- Cited by
- 573
- References
- 218
- Citations by year
- 2026: 43 · 2025: 64 · 2024: 76 · 2023: 85 · 2022: 61 · 2021: 93 · 2020: 77 · 2019: 47 · 2018: 26
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Association for the Study of Liver Diseases
- Vienna Science and Technology Fund
- Austrian Science Fund (F3008‐B19, F3517-B20, F3008, F3517)
- Fondo Nacional de Ciencia y Tecnología
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, pathogenesis, insulin resistance, lipotoxicity, endoplasmic reticulum stress, autophagy, liver inflammation, hepatic stellate cell activation, liver fibrosis, liver cirrhosis, hepatic lipid accumulation, gut microbiota, obesity, Western diet, genetic variants, cardiometabolic risk
- MeSH terms
- Animals, Humans, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
